296 related articles for article (PubMed ID: 9328140)
1. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma.
Vora AR; Rodgers S; Parker AJ; Start R; Rees RC; Murray AK
Br J Cancer; 1997; 76(7):836-44. PubMed ID: 9328140
[TBL] [Abstract][Full Text] [Related]
2. Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.
Grandis JR; Falkner DM; Melhem MF; Gooding WE; Drenning SD; Morel PA
Clin Cancer Res; 2000 Jul; 6(7):2794-802. PubMed ID: 10914726
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient.
Kovalcsik E; John J; Turner M; Birchall L; Sage D; Whittle R; Dalgleish A; Pandha H
Melanoma Res; 2004 Dec; 14(6):463-71. PubMed ID: 15577316
[TBL] [Abstract][Full Text] [Related]
4. Mutation in the beta 2m gene is not a frequent event in head and neck squamous cell carcinomas.
Feenstra M; Rozemuller E; Duran K; Stuy I; van den Tweel J; Slootweg P; de Weger R; Tilanus M
Hum Immunol; 1999 Aug; 60(8):697-706. PubMed ID: 10439315
[TBL] [Abstract][Full Text] [Related]
5. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
Korkolopoulou P; Kaklamanis L; Pezzella F; Harris AL; Gatter KC
Br J Cancer; 1996 Jan; 73(2):148-53. PubMed ID: 8546899
[TBL] [Abstract][Full Text] [Related]
6. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas.
Feenstra M; Veltkamp M; van Kuik J; Wiertsema S; Slootweg P; van den Tweel J; de Weger R; Tilanus M
Tissue Antigens; 1999 Sep; 54(3):235-45. PubMed ID: 10519360
[TBL] [Abstract][Full Text] [Related]
7. HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis.
Bandoh N; Ogino T; Katayama A; Takahara M; Katada A; Hayashi T; Harabuchi Y
Oncol Rep; 2010 Apr; 23(4):933-9. PubMed ID: 20204276
[TBL] [Abstract][Full Text] [Related]
8. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
[TBL] [Abstract][Full Text] [Related]
9. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
10. HLA and MICA associations with head and neck squamous cell carcinoma.
Reinders J; Rozemuller EH; Otten HG; van der Veken LT; Slootweg PJ; Tilanus MG
Oral Oncol; 2007 Mar; 43(3):232-40. PubMed ID: 16857416
[TBL] [Abstract][Full Text] [Related]
11. HLA class I alterations in head and neck squamous cell carcinoma.
Murray AK; Vora AR; Parker AJ; Start R; Rees RC
Biochem Soc Trans; 1997 May; 25(2):266S. PubMed ID: 9191310
[No Abstract] [Full Text] [Related]
12. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours.
Cromme FV; van Bommel PF; Walboomers JM; Gallee MP; Stern PL; Kenemans P; Helmerhorst TJ; Stukart MJ; Meijer CJ
Br J Cancer; 1994 Jun; 69(6):1176-81. PubMed ID: 8198988
[TBL] [Abstract][Full Text] [Related]
13. Lack of HLA-class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression.
Corrias MV; Occhino M; Croce M; De Ambrosis A; Pistillo MP; Bocca P; Pistoia V; Ferrini S
Tissue Antigens; 2001 Feb; 57(2):110-7. PubMed ID: 11260505
[TBL] [Abstract][Full Text] [Related]
14. Constitutive transduction of peptide transporter and HLA genes restores antigen processing function and cytotoxic T cell-mediated immune recognition of human melanoma cells.
White CA; Thomson SA; Cooper L; van Endert PM; Tampe R; Coupar B; Qiu L; Parsons PG; Moss DJ; Khanna R
Int J Cancer; 1998 Feb; 75(4):590-5. PubMed ID: 9466661
[TBL] [Abstract][Full Text] [Related]
15. Loss of expression of antigen-presenting molecules in human pancreatic cancer and pancreatic cancer cell lines.
Pandha H; Rigg A; John J; Lemoine N
Clin Exp Immunol; 2007 Apr; 148(1):127-35. PubMed ID: 17302733
[TBL] [Abstract][Full Text] [Related]
16. HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sites.
Mattijssen V; De Mulder PH; Schalkwijk L; Manni JJ; Van 't Hof-Grootenboer B; Ruiter DJ
Int J Cancer Suppl; 1991; 6():95-100. PubMed ID: 2066187
[TBL] [Abstract][Full Text] [Related]
17. Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression.
Keating PJ; Cromme FV; Duggan-Keen M; Snijders PJ; Walboomers JM; Hunter RD; Dyer PA; Stern PL
Br J Cancer; 1995 Aug; 72(2):405-11. PubMed ID: 7640226
[TBL] [Abstract][Full Text] [Related]
18. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.
Cromme FV; Airey J; Heemels MT; Ploegh HL; Keating PJ; Stern PL; Meijer CJ; Walboomers JM
J Exp Med; 1994 Jan; 179(1):335-40. PubMed ID: 8270878
[TBL] [Abstract][Full Text] [Related]
19. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
Glew SS; Duggan-Keen M; Cabrera T; Stern PL
Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
[TBL] [Abstract][Full Text] [Related]
20. A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway.
Teisserenc H; Schmitt W; Blake N; Dunbar R; Gadola S; Gross WL; Exley A; Cerundolo V
Immunol Lett; 1997 Jun; 57(1-3):183-7. PubMed ID: 9232449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
